Stock forecast & analyst price target predictions based on 13 analysts offering 12-month price targets for CRSP in the last 3 months.
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats ...
Investing in biotechnology stocks has always required a high risk tolerance and the patience to wait years, even decades, for results. These companies drive medical innovation, developing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results